The Group is headquartered in Villepinte (12 km from Paris, France) near the Roissy-Charles de Gaulle airport. Most of the company's support functions can be found here (Quality, HR, Information Systems, Purchasing, Communication, Finance, Strategic Projects, Development, Medical and Regulatory Affairs, etc.).
With an organizational structure based on centers of competences, Group Innovation focuses on discovering and developing medical imaging solutions for the future. Our R&D centers are based in France (for contrast media, injection systems and digital solutions), in Israel (for medical devices dedicated to interventional radiology) and in the USA (for injection systems).
Guerbet owns 8 manufacturing specialized facilities. Our sites in Marans and Lanester (France) and in Dublin (Ireland) manufacture active pharmaceutical ingredients for our MRI, X-Ray and Interventional Imaging products range. Our sites in Aulnay-sous-Bois (France), Rio de Janeiro (Brazil) and Raleigh (USA) are dedicated to fill-and-finish of contrast media. Our sites in Saint-Priest (Lyon, France) and Cincinnati (USA) are dedicated to imaging solutions (injectors, disposables) and services.
Guerbet operates with a network of distribution centers across all markets to supply our clients under the best conditions in terms of lead-times and quality.
This supply chain is fed by regional distribution platforms located in Europe, Asia, North America and South America.
Guerbet distributes its products and services across five continents. The Group is directly present in key markets. Contrast Media and Delivery Systems (CMDS) business acquired from Mallinckrodt on November 27, 2015 has reinforced our position all over the world, especially in Europe and America.
Thirteen affiliates in Europe:
Guerbet is well established in Latin America and is expanding its presence in the North American market.
The dynamic nature of the Asia-Pacific market offers the Group substantial potential for growth.